Ongoing developments at the LEAP Research and Innovation District in Boone County were among the most significant local tech stories of 2024. Progress continued this year on LEAP, which stands for ...

So far, Eli Lilly and ... the Indiana Economic Development Corp.—the state’s job creation agency—started securing options to buy some 9,000 acres of land west of Lebanon for LEAP.

The City of Lebanon ran out of water to allocate for new construction in May and stopped issuing building permits after Eli Lilly and Co ... And Central Indiana in general is suffering a water ...

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

Chris Schott, an analyst from J.P. Morgan, maintained the Buy rating on Eli Lilly & Co (LLY – Research Report). The associated price target ...

As expected by many, Eli Lilly And Co (NYSE:LLY) filed a motion to intervene as a defendant in a case between the Outsourcing Facilities Association and FarmaKeio Custom Compounding against the FDA.

Reports indicate he was actually taking Eli Lilly's (NYSE: LLY) weight-loss drug Mounjaro. Eli Lilly's stock has been a strong winner over the past few years, powered by its portfolio of glucagon ...

Eli Lilly and Co. CEO David Ricks—IBJ ... high of $972 and announcements about big new investments in Lebanon and Ireland. Lilly’s stock price has retreated since that high mark, but Lilly ...

Additionally, Eli Lilly (NYSE:LLY) announced a substantial $4.5 billion investment in October for the construction of the Lilly Medicine Foundry in Lebanon, Indiana, scheduled to open in 2027.

Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the “entitlement” some ...

(Image Credits: Pixabay) It has been a year since the launch of Zepbound (tirzepatide) for obesity, and Eli Lilly’s competition with Novo Nordisk continues. Zepbound’s superior efficacy and ...